Protocol Ledger

NCT06590896 · Phase II · RECRUITING

Safety of Cenobamate in Japanese Subjects With Partial Onset Seizures

Interventional Phase II clinical trial protocol NCT06590896 sponsored by Ono Pharmaceutical Co in Neurology, Psychiatry, and Pain, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2022-11-04 Enrollment: 100 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT06590896
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)100 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)2 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT06590896
Protocol FieldVerified Registry Value
NCT IdentifierNCT06590896
Consolidated Lead SponsorOno Pharmaceutical Co
Therapeutic Condition CohortNeurology, Psychiatry, and Pain
Clinical Trial PhasePhase II
Overall Recruitment StatusRECRUITING
Registered Enrollment100 participants (ESTIMATED)
Registered Start Date2022-11-04
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT06590896
Hospital Research SiteLocationSite Profile
Hiroshima University HospitalHiroshima, JapanOpen Hospital Dossier ->
Kagoshima University HospitalKagoshima, JapanOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Neurology, Psychiatry, and Pain Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI